MedTrace Logo

Treatment of Breast Fibroadenoma With High Intensity Focused Ultrasound (HIFU)

NCT03022695 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 27

Last updated 2024-07-22

No results posted yet for this study

Summary

This is a monocenter, open-label, uncontrolled study in accordance with §23b MPG to evaluate the efficacy of the HIFU-treatment of fibroadenoma using the TH-One device.

Conditions

  • Breast Fibroadenoma

Interventions

DEVICE

High Intensity Focused Ultrasound

Sponsors & Collaborators

  • Theraclion

    collaborator INDUSTRY

  • University Hospital Tuebingen

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-10-31
Primary Completion
2015-11-30
Completion
2015-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03022695 on ClinicalTrials.gov